Loading...
Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab
Thrombotic thrombocytopenic purpura (TTP) is a rare and unpredictable disease with a high mortality rate (90%) if untreated. It results from systemic microvascular thrombosis and leads to profound thrombocytopenia, hemolytic anemia and organ failure of varying severity. However, macrovascular thromb...
Saved in:
| Published in: | J Hematol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elmer Press
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430863/ https://ncbi.nlm.nih.gov/pubmed/32855757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jh614 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|